Literature DB >> 8287880

Parametric phase display for biventricular function from gated cardiac blood pool single-photon emission tomography.

D R Neumann1, R T Go, B A Myers, W J MacIntyre, E Q Chen, S A Cook.   

Abstract

Complete assessment of biventricular function from planar ECG-gated cardiac blood pool studies has been limited because of the overlap of adjacent activity-containing structures. Theoretically, single-photon emission tomography (SPET) can be used to comprehensively evaluate both ventricles by isolating them from surrounding anatomy. However, an enormous amount of parametric data is generated from gated SPET studies, and much of it is diagnostically irrelevant for ventricular wall motion analysis. To compress this information to a more easily interpretable format, a two-dimensional parametric display has been developed. Fourier analysis of short-axis tomograms from a gated cardiac blood pool SPET study generates three-dimensional, first-harmonic phase data. Circumferential profile data from the parametric tomograms of the right and left ventricle are mapped onto a two-dimensional polar display. This method is demonstrated in a normal patient and in three patients with abnormal ventricular contraction patterns and appears to have potential application for the analysis and characterization of biventricular wall motion.

Entities:  

Mesh:

Year:  1993        PMID: 8287880     DOI: 10.1007/BF00173492

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  6 in total

1.  Reconstruction of Fourier coefficients: a fast method to get polar amplitude and phase images of gated SPECT.

Authors:  G Graf; J Mester; M Clausen; E Henze; F Bitter; P Heidenreich; W E Adam
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

2.  Two dimensional polar display of cardiac blood pool SPECT.

Authors:  N Honda; K Machida; T Mamiya; T Takahashi; T Takishima; N Hasegawa; M Hashimoto; K Ohno; H Matsuo; N Yoshimoto
Journal:  Eur J Nucl Med       Date:  1989

3.  A new method of three dimensional analysis of left ventricular wall motion.

Authors:  K Yamashita; M Tanaka; N Asada; T Matsushita; Y Hasegawa; Y Ishii; H Ishihara; S Ri; N Tamaki
Journal:  Eur J Nucl Med       Date:  1988

4.  Right ventricular infarction. Clinical and hemodynamic features.

Authors:  J N Cohn; N H Guiha; M I Broder; C J Limas
Journal:  Am J Cardiol       Date:  1974-02       Impact factor: 2.778

5.  Functional mapping of ventricular contraction and phase using single-photon emission computed tomography (SPECT).

Authors:  K Nakajima; M Taniguchi; H Bunko; N Tonami; K Hisada
Journal:  Nucl Med Commun       Date:  1986-11       Impact factor: 1.690

6.  The phase image: its relationship to patterns of contraction and conduction.

Authors:  E Botvinick; R Dunn; M Frais; W O'Connell; D Shosa; R Herfkens; M Scheinman
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

  6 in total
  3 in total

1.  Evaluation of left ventricular wall motion, volumes, and ejection fraction by gated myocardial tomography with technetium 99m-labeled tetrofosmin: a comparison with cine magnetic resonance imaging.

Authors:  P Vaduganathan; Z X He; G W Vick; J J Mahmarian; M S Verani
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  Optimal 3-dimensional method for right and left ventricular fourier phase analysis in electrocardiography-gated blood-pool SPECT.

Authors:  D Vilain; D Daou; D Casset-Senon; M Faraggi; D Le Guludec
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

3.  Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging in patients with left ventricular dysfunction and conduction disturbances.

Authors:  Mark A Trimble; Salvador Borges-Neto; Stuart Smallheiser; Ji Chen; Emily F Honeycutt; Linda K Shaw; Jaekyeong Heo; Robert A Pagnanelli; E Lindsey Tauxe; Ernest V Garcia; Fabio Esteves; Frank Seghatol-Eslami; G Neal Kay; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2007-04-18       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.